LAPAD: The Effect of Adhesiolysis During Elective Abdominal Surgery on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs

Sponsor
Radboud University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01236625
Collaborator
(none)
752
1
32
23.5

Study Details

Study Description

Brief Summary

Official title:

LAPAD - A prospective study on the effect of adhesiolysis during elective laparotomy or laparoscopy on per- and postoperative complication, quality of life and socioeconomic costs

Background:

With improved surgical technology and ageing of the population the number of reoperations in the abdomen dramatically increases. The risk for a repeat laparotomy or laparoscopy is a high as 30% in the first ten years after a laparotomy. In over 95% of reoperations adhesiolysis is required to gain access to the abdominal cavity and operation area. Adhesiolysis significantly increases the risk for inadvertent organ damage, such as enterotomies, leading to higher morbidity, mortality and socioeconomic costs.

Purpose:

To define the impact of adhesiolysis on per- and postoperative complications, quality of life and socioeconomic costs.

Design:

Prospective observational study.

Primary outcomes:
  • adhesiolysis time

  • inadvertent enterotomy

  • seromuscular injury

  • miscellaneous organ damage

  • Serious adverse events of operation (anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death)

Secondary outcomes:
  • Hospital stay

  • Intensive care admission

  • Reinterventions

  • In-hospital costs

  • Parenteral feeding

  • Short term readmissions (30 days)

  • Quality of life (Gastro- intestinal tract complaints, Short Form- 36(SF-36), DASI (Duke Activity Score Index(DASI) )

Estimated enrollment: 800 start study: 1 june 2008 Inclusion completion date: 1 june 2010 Estimated study completion date: 1 february 2011

Condition or Disease Intervention/Treatment Phase
  • Procedure: Adhesiolysis

Study Design

Study Type:
Observational
Actual Enrollment :
752 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Study on the Effect of Adhesiolysis During Elective Laparotomy or Laparoscopy on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs
Study Start Date :
Jun 1, 2008
Actual Primary Completion Date :
Feb 1, 2011
Actual Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
No adhesiolysis

All patient undergoing elective laparotomy or laparoscopy with no need for adhesiolysis during the procedure.

Adhesiolysis

All patient undergoing elective laparotomy or laparoscopy requiring adhesiolysis during the procedure.

Procedure: Adhesiolysis
Blunt or sharp dissection of adhesive tissue.

Outcome Measures

Primary Outcome Measures

  1. Inadvertent Enterotomy [Day of surgery (one day)]

    Every unintended and iatrogenic full thickness defect of the bowel.

  2. Seromuscular Injury [Day of surgery (one day)]

    Every visible damage to the serosa, without leakage or exposure of the bowel lumen.

  3. Miscellaneous Organ Damage [Day of surgery (one day)]

    Unintended iatrogenic damage to intra- peritoneal organs and structures other than bowel. E.g. Spleen, liver, pancreas or ureter.

  4. Serious Adverse Events [30 days]

    Complications marked as SAE: anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death

  5. Adhesiolysis Time [Day of surgery (one day)]

    Time required to dissect adhesive tissue.

Secondary Outcome Measures

  1. Hospital stay [From surgery to discharge]

    Number of days from surgery until discharge

  2. Reinterventions [30 days after discharge]

    Emergency reoperation related to a complication of initial surgery within max. 30 days after discharge.

  3. In- hospital Costs [From surgery to discharge]

    Direct costs comprising costs from operation, stay on ward and Intesive Care Unit, medication use, diagnostics.

  4. Parenteral Feeding [From surgery to discharge]

    Number of days that patient required parenteral feeding.

  5. Short term readmissions [30 days after discharge]

    Readmissions to the hospital related to complication of surgery.

  6. Quality of life [6 months post surgery]

    Quality of life as measured with SF-36, Gastro- intestinal tract complaints and DASI index.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Planned elective laparotomy or laparoscopy

  • Mentally competent

  • 18 years or older

Exclusion Criteria:
  • Operation cancelled

  • Bad quality of data

Contacts and Locations

Locations

Site City State Country Postal Code
1 Radboud University Nijmegen Medical Center Nijmegen Gelderland Netherlands 6500HB

Sponsors and Collaborators

  • Radboud University Medical Center

Investigators

  • Study Director: Harry van Goor, MD, PhD, FRCS, Radboud University Nijmegen Medical Center
  • Principal Investigator: Richard PG ten Broek, BsC, Radboud University Nijmegen Medical Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Radboud University Medical Center
ClinicalTrials.gov Identifier:
NCT01236625
Other Study ID Numbers:
  • RU-RTB-0003
First Posted:
Nov 7, 2010
Last Update Posted:
Nov 2, 2012
Last Verified:
Sep 1, 2010
Keywords provided by Radboud University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2012